those that got sinovac as primary vaccine should get cansino as booster for more protection against covid. that is the latest research study by china. imagine how many of us in Malaysia got sinovac intially then take cansino as booster. the bussiness will be good

GMP approval

做疫苗的公司再怎么赚钱也好，也算是一种善举。希望管理层可以好好做生意，不要太过操作股价。生意好，股价就起。

Solution is selling RM 57 per dose for Malaysia government and will get RM 200 mil for 3.5 mil doses. and selling price usually higher for private companies - so far there are 10 + plus companies interested. not to mention sales from Thailand and Philippines. I think worth to hold longer and see how this company run.